JOURNAL OF TRANSLATIONAL MEDICINE, cilt.4, 2006 (SCI-Expanded)
Background: Thyroid papillary microcarcinoma (TPM) is defined according to WHO criteria as a thyroid tumor smaller than 1 - 1.5 cm. TPMs are encountered in 0.5 - 35.6 % of autopsies or surgical specimens where carcinoma had been unsuspected. The purpose of the present study was to evaluate patients who had TPMs in terms of clinical findings, histopathological features and immunohistochemical evidence of expression of the tumor suppressor gene p53.